New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access Is Easy. Choosing the Right ETF Is Not

With 1,790 launches through July 2026, finding an ETF is easy and choosing one is not. 46% of share classes hold under $50 million, and nearly 7 in 10 allocators are reassessing their holdings, with portfolio fit the top criterion. See how 620 professionals select ETFs.

Trackinsight Global ETF Survey 2026
GDOC

Goldman Sachs Future Health Care Equity ETF

The GDOC Exchange Traded Fund (ETF) is provided by Goldman Sachs. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$36.87
-$0.46 (-1.23%) yesterday
1:30 PM 10/16/26 Closed
1D price range
$36.87$36.89
52W price range
$31.32$38.66
YTD Perf.
+3.66%
YTD Flows
Annualized volatility
Fund AuM
€17M
Share class AuM
€17M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US38149W7700
TER
0.75%
Inception date
11/11/2021
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Oct 16, 2026
-10%-5%0%5%10%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 08/31/26
Healthcare
97.08%
Unavailable
2.92%
Latest GDOC news

No content available for this fund

FAQ about GDOC

GDOC is a Active ETF. This ETF provides exposure to Other Global Equities.
GDOC carries a total expense ratio (TER) of 0.75%, indicating the annual cost for holding the fund.
GDOC was introduced to the market on November 11, 2021. It trades on United States
Goldman Sachs Future Health Care Equity ETF, GDOC, is provided by Goldman Sachs. Learn more about Goldman Sachs here.
GDOC oversees €17M in assets as of October 16, 2026.
GDOC follows a distributing dividend policy, meaning it pays out income to investors. As of October 16, 2026, its 12-month trailing yield was 0.31%.
As of August 31, 2026, GDOC has significant geographic allocations in USA, United Kingdom and Switzerland.
As of August 31, 2026, GDOC focuses largely on Healthcare.
As of August 31, 2026, GDOC holds 37 positions in its portfolio, with 71.20% of assets concentrated in its top 15 holdings.
As of August 31, 2026, GDOC top three holdings include Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc..
The base currency of GDOC is USD.
Data as of 08/31/26
Eli Lilly & Co.
12.25%
Johnson & Johnson
8.25%
Merck & Co., Inc.
7.53%
UnitedHealth Group, Inc.
5.82%
Guardant Health, Inc.
4.22%
Vertex Pharmaceuticals, Inc.
4.12%
argenx SE
4.11%
DexCom, Inc.
3.69%
Thermo Fisher Scientific, Inc.
3.52%
Agilent Technologies, Inc.
3.47%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight